FRAUD | November 2009 | Issue No 88 |
Mexico’s Shadow Pharma Market
 An in-depth investigation reveals a host of problems afflicting Mexico’s pharmaceutical industry. Counterfeiting, theft and illegal sales of samples cost drug-makers nearly US$2 billion a year.
|
To read Tendencias articles, please
LOG IN
if you are already a subscriber
or
REGISTER if you are not. Registering
is quick and painless. Thank you.
Kroll commissioned the Economist Intelligence Unit to conduct a worldwide survey on fraud and its effect on business in 2009/2010.
Kroll's Global Fraud Report brings together these survey results with the experience and expertise of Kroll and a selection of its affiliates.
more
Browse Archive